| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0002678 | Positive regulation of chronic inflammatory response | Increases phenotype | PMID:35526705 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:22422511 |
| GO:0004053 | Arginase activity | Increases phenotype | PMID:32864810 |
| GO:0004364 | Glutathione transferase activity | Decreases phenotype | PMID:32864810 |
| GO:0004602 | Glutathione peroxidase activity | Affects phenotype | PMID:25724285; PMID:32864810 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:22422511; PMID:25724285; PMID:32864810 |
| GO:0005391 | P-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:32864810 |
| GO:0006004 | Fucose metabolic process | Affects phenotype | PMID:32864810 |
| GO:0006054 | N-acetylneuraminate metabolic process | Affects phenotype | PMID:32864810 |
| GO:0006309 | Apoptotic dna fragmentation | Increases phenotype | PMID:7673702 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:25724285; PMID:29408668 |
| GO:0006882 | Cellular zinc ion homeostasis | Affects phenotype | PMID:32661532 |
| GO:0006909 | Phagocytosis | Affects phenotype | PMID:32712770 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:27017951; PMID:29408668; PMID:32712770; PMID:36450499; PMID:7673702 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:27017951 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:16959597 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:39106537 |
| GO:0007614 | Short-term memory | Decreases phenotype | PMID:36265761 |
| GO:0007625 | Grooming behavior | Decreases phenotype | PMID:35526705 |
| GO:0007628 | Adult walking behavior | Decreases phenotype | PMID:35526705 |
| GO:0008219 | Cell death | Increases phenotype | PMID:26865462; PMID:32712770 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:24962574 |
| GO:0009725 | Response to hormone | Increases phenotype | PMID:35526705 |
| GO:0010035 | Response to inorganic substance | Increases phenotype | PMID:35526705 |
| GO:0010259 | Multicellular organism aging | Increases phenotype | PMID:35526705 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Decreases phenotype | PMID:27017951 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:25724285; PMID:27270452 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:29408668 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:32864810 |
| GO:0019318 | Hexose metabolic process | Affects phenotype | PMID:32864810 |
| GO:0019627 | Urea metabolic process | Increases phenotype | PMID:35526705 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:35526705 |
| GO:0030317 | Flagellated sperm motility | Decreases phenotype | PMID:39106537 |
| GO:0032275 | Luteinizing hormone secretion | Decreases phenotype | PMID:39106537 |
| GO:0033484 | Cellular nitric oxide homeostasis | Decreases phenotype | PMID:35526705 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:35526705 |
| GO:0035640 | Exploration behavior | Decreases phenotype | PMID:35526705 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:39106537 |
| GO:0042133 | Neurotransmitter metabolic process | Increases phenotype | PMID:35526705 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:32712770; PMID:36450499 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:35526705 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:27017951 |
| GO:0046449 | Creatinine metabolic process | Increases phenotype | PMID:35526705 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:16865776 |
| GO:0046884 | Follicle-stimulating hormone secretion | Decreases phenotype | PMID:39106537 |
| GO:0055070 | Copper ion homeostasis | Decreases phenotype | PMID:24368744 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:32712770 |
| GO:0070459 | Prolactin secretion | Increases phenotype | PMID:39106537 |
| GO:0071578 | Zinc ion import across plasma membrane | Decreases phenotype | PMID:30635848 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:24412756; PMID:25724285; PMID:32712770 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:35526705; PMID:39106537 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Decreases phenotype | PMID:24368744 |
| GO:1901687 | Glutathione derivative biosynthetic process | Decreases phenotype | PMID:24368744 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:39106537 |
| GO:1902553 | Positive regulation of catalase activity | Decreases phenotype | PMID:24368744 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:27017951; PMID:29408668 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.